Monthly Archives: November 2012

Psoriasis and Arthritis Relief
arthritisandpsoriasis.com - Psoriatic arthritis (PA)is one of the most common forms of inflammatory arthritis. Like its not so distant cousin, rheumatoid arthritis, Psoriasis Relief Arthritis Relief Psoriatic Arthritis Psoriasis Treatment http://www.youtube.comFrom:psoriasisarthritis1Views:2 0ratingsTime:01:27More inPeople Blogs

Link:
Psoriasis and Arthritis Relief - Video

Dr Michael D Seidman the Science behind the Visalus Vi-Pack extended Part 1 of 2
http://www.challenge-bodybyvi.com Dr Michael D. Seidman voted in the top 1% of Doctor #39;s in his field explains the Vi-Pak formulation which he developed after 25 years of research. The ViSalus web site says that the Vi-pak is Anti-Fatigue - Offers prolonged energy and endurance Anti-Tumor - Potentially reduces risk of some types of tumors Anti-Carcinogen - Potentially reduces risk of some types of cancers Anti-Aging - Reduces effects of aging and potential threat of degenerative diseases Increased Performance - Can increase growth hormone levels to promote muscle growth and prevent muscle breakdown Antioxidant - Chelated for increased absorption and efficacy Hypo-tensive - Effects that potentially lower blood pressure Cognitive Enhancement - Promotes healthy memory and cognitive brain function Anti-ADHD - Helps manage the effects found in Attention Deficit Hyperactivity Disorder (ADHD) Anti-Alzheimer #39;s - Helps prevent Alzheimer #39;s and other dementia Anti-Inflammatory - Alleviates pain and/or symptoms from chronic inflammatory conditions such as rheumatoid arthritis, multiple sclerosis, eczema and psoriasis Anti-Menopausal - Relieves symptoms of PMS and menopause Hypoglycemic - Some experience lowered blood sugar (anti diabetic effect) Immunostimulant - Improves the body #39;s natural immune function Antilipidemic - Effects that can lower blood fat Anti-obesity - Helps with weight loss Anti Atherosclerosis - Helps prevent the hardening of arteries Cardio Protective - Promotes healthy ...From:ShareNGetPaidViews:0 0ratingsTime:14:47More inPeople Blogs

See more here:
Dr Michael D Seidman the Science behind the Visalus Vi-Pack extended Part 1 of 2 - Video

Dr Michael D Seidman the Science behind the Visalus Vi-Pack extended 2 of 2.
http://www.challenge-bodybyvi.com Dr Michael D. Seidman voted in the top 1% of Doctor #39;s in his field explains the Vi-Pak formulation which he developed after 25 years of research. The ViSalus web site says that the Vi-pak is Anti-Fatigue - Offers prolonged energy and endurance Anti-Tumor - Potentially reduces risk of some types of tumors Anti-Carcinogen - Potentially reduces risk of some types of cancers Anti-Aging - Reduces effects of aging and potential threat of degenerative diseases Increased Performance - Can increase growth hormone levels to promote muscle growth and prevent muscle breakdown Antioxidant - Chelated for increased absorption and efficacy Hypo-tensive - Effects that potentially lower blood pressure Cognitive Enhancement - Promotes healthy memory and cognitive brain function Anti-ADHD - Helps manage the effects found in Attention Deficit Hyperactivity Disorder (ADHD) Anti-Alzheimer #39;s - Helps prevent Alzheimer #39;s and other dementia Anti-Inflammatory - Alleviates pain and/or symptoms from chronic inflammatory conditions such as rheumatoid arthritis, multiple sclerosis, eczema and psoriasis Anti-Menopausal - Relieves symptoms of PMS and menopause Hypoglycemic - Some experience lowered blood sugar (anti diabetic effect) Immunostimulant - Improves the body #39;s natural immune function Antilipidemic - Effects that can lower blood fat Anti-obesity - Helps with weight loss Anti Atherosclerosis - Helps prevent the hardening of arteries Cardio Protective - Promotes healthy ...From:ShareNGetPaidViews:0 0ratingsTime:10:42More inPeople Blogs

Read more here:
Dr Michael D Seidman the Science behind the Visalus Vi-Pack extended 2 of 2. - Video

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/3xwhrb/chronic_plaque) has announced the addition of GlobalData's new report "Chronic Plaque Psoriasis Global Clinical Trials Review, H2, 2012" to their offering.

This report provides elemental information and data relating to the clinical trials on Chronic Plaque Psoriasis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Chronic Plaque Psoriasis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by a team of industry experts.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations

- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner

- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more

See the article here:
Research and Markets: Chronic Plaque Psoriasis Global Clinical Trials Review, H2, 2012

By Kathleen Doheny HealthDay Reporter

MONDAY, Nov. 19 (HealthDay News) -- Children who have the skin condition psoriasis are about twice as likely to be either overweight or obese as kids without the skin problem, according to new research that looked at children from nine countries.

When researchers looked at just obesity, they found those with the skin condition were four times as likely to be obese, said Dr. Amy Paller, a professor and chair of dermatology at Northwestern University Feinberg School of Medicine, who led the study. It is published online Nov. 19 in the Archives of Dermatology.

U.S. children with severe psoriasis were seven times as likely to be obese as children without the skin condition.

"Pediatric psoriasis is a little bit of an orphan," Paller said. "It's very little studied."

She decided to take a closer look, especially because much research has shown that adults with psoriasis are often overweight. Experts have found a link, not cause and effect.

Psoriasis is marked by red, often itchy and scaly lesions. They can be confined to just some areas, such as the scalp and elbows, or cover much of the body.

The condition can make children self-conscious, affecting their social life and willingness to exercise, among other things, according to Paller.

She evaluated 614 children, ages 5 to 17. While 409 had psoriasis, 205 did not and served as the comparison group.

Of those with psoriasis, about half had mild forms and the other half severe.

Follow this link:
Kids With Psoriasis More Likely to Be Overweight: Study